Legal & General Group
MBIO icon

Legal & General Group’s Mustang Bio MBIO Stock Holding History

Legal & General Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7
Closed -$3K – 3474
2022
Q2 		$3K Hold
7
– – ﹤0.01% 3477
2022
Q1 		$6K Hold
7
– – ﹤0.01% 3487
2021
Q4 		$9K Hold
7
– – ﹤0.01% 3476
2021
Q3 		$15K Hold
7
– – ﹤0.01% 3364
2021
Q2 		$18K Hold
7
– – ﹤0.01% 3329
2021
Q1 		$18K Hold
7
– – ﹤0.01% 3174
2020
Q4 		$21K Buy
7
+2
+40% +$4.78K ﹤0.01% 3070
2020
Q3 		$11K Sell
5
-1
-17% -$2.46K ﹤0.01% 3197
2020
Q2 		$15K Hold
6
– – ﹤0.01% 3184
2020
Q1 		$12K Sell
6
-2
-25% -$5.13K ﹤0.01% 3114
2019
Q4 		$24K Buy
8
+2
+33% +$4.58K ﹤0.01% 3132
2019
Q3 		$16K Hold
6
– – ﹤0.01% 3195
2019
Q2 		$18K Buy
6
+3
+100% +$8.56K ﹤0.01% 3241
2019
Q1 		$8K Hold
3
– – ﹤0.01% 3276
2018
Q4 		$7K Hold
3
– – ﹤0.01% 3306
2018
Q3 		$15K Hold
3
– – ﹤0.01% 3270
2018
Q2 		$17K Buy
+3
New +$18.9K ﹤0.01% 3226

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's MBIO Position: Q3 2022 in Review

Legal & General Group sold out of Mustang Bio (MBIO) in Q3 2022, closing a stake of 7 shares — an estimated $3K sold.

Legal & General Group first reported a position in MBIO in Q2 2018 and held it in 17 quarters. The position peaked at $24K in Q4 2019. 67 funds tracked by Wall St. Rank hold MBIO as of Q3 2022.

  • Legal & General Group reported no remaining Mustang Bio position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 7 Mustang Bio shares in Q3 2022, an estimated $3K.
  • Legal & General Group first reported a position in Mustang Bio in Q2 2018 and held it in 17 quarters.
  • Legal & General Group's Mustang Bio position peaked at $24K in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.